Fundies.
English

LISATA THERAPEUTICS, INC.

EDGAR
CLBS Current report (8-K) · filed 2026-10-14

Annual consolidated revenue for 2025: about USD 200K, using the latest reported figures. The previous period, 2024, was about USD 1M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

0 USD

2026 Q2 · USD

Exact inputs and evidence

Operating cash flow

-2.65 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -5732000 USD Source
  • Operating Cash Flow: -3083000 USD Source

Free cash flow

-2.65 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: -5732000 USD Source
  • Operating Cash Flow: -3083000 USD Source
  • Capital Expenditure: 0 USD Source
  • Capital Expenditure: 0 USD Source
Cash and cash equivalents
10.4 million USD Source
Exact value

10400000 USD

Long-term debt including current maturities
4.89 million USD Source
Exact value

4894400 USD

Shares outstanding
9.12 million shares Source
Exact value

9119004 shares

Reported share-count change

5.71% · 493 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 8626464 shares · 2025-06-30· Source
  • 9119004 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

130 thousand USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Revenue: 0 USD · 2025-07-01 – 2025-09-30 Source
  • Revenue: 200000 USD · 2025-01-01 – 2025-12-31 Source
  • Revenue: 70000 USD · 2025-01-01 – 2025-09-30 Source
  • Revenue: 0 USD · 2026-01-01 – 2026-03-31 Source
  • Revenue: 0 USD · 2026-04-01 – 2026-06-30 Source

Net income

-14.6 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Net income: -4249000 USD · 2025-07-01 – 2025-09-30 Source
  • Net income: -16586000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -13632000 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -4489000 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -2929000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-12.3 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: -12700000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -9358000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -15949000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -12700000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -3083000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -5732000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -3083000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

0 USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Capital expenditure: 28000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 28000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 28000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 28000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

-12.3 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: -12700000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -9358000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -15949000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -12700000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -3083000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -5732000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -3083000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 28000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 28000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 28000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 28000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 0 USD · 2026-01-01 – 2026-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-14.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 6 of 11 periods available· newest 2025-12-31
  • Operating income: 11 of 11 periods available· newest 2025-12-31
  • Net income: 10 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 11 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 11 of 11 periods available· newest 2025-12-31
  • Total assets: 6 of 11 periods available· newest 2025-12-31
  • Total liabilities: 6 of 11 periods available· newest 2025-12-31
  • Current assets: 6 of 11 periods available· newest 2025-12-31
  • Current liabilities: 6 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 6 of 11 periods available· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 6 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    -80%

    Prior period

    USD 1 million

    –

    Current period

    USD 200,000

    –

    Exact inputs and evidence

    200000 − 1000000 = -800000 USD

    1000000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    200000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 3.4 million

    Prior period

    −USD 19.99 million

    –

    Current period

    −USD 16.59 million

    –

    Exact inputs and evidence

    -16586000 − -19985000 = 3399000 USD

    -19985000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -16586000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 3.41 million

    Prior period

    −USD 19.36 million

    –

    Current period

    −USD 15.95 million

    –

    Exact inputs and evidence

    -15949000 − -19356000 = 3407000 USD

    -19356000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -15949000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +USD 28,000

    Prior period

    USD 0

    –

    Current period

    USD 28,000

    –

    Exact inputs and evidence

    28000 − 0 = 28000 USD

    0 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    28000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue USD 200,000 100% of revenue
  • Operating costs Derived USD 18.41 million 9,205% of revenue
  • Operating income −USD 18.21 million −9,105% of revenue
  • Tax, interest and other Derived −USD 1.62 million −812% of revenue
  • Net income −USD 16.59 million −8,293% of revenue

Cash

  • Operating cash flow −USD 15.95 million −7,975% of revenue
  • Capital expenditure USD 28,000 14% of revenue
  • Free cash flow Derived −USD 15.98 million −7,989% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2016 Operating loss: operating costs were 184% of revenue.
  • 2022 Not shown: operating income or net income is not reported.
  • 2023 Not shown: operating income or net income is not reported.
  • 2024 Operating loss: operating costs were 2,341% of revenue.
  • 2025 Operating loss: operating costs were 9,205% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2016 2016-01-01 – 2016-12-3135283868 64785816 Derived -29501948 3154371 Derived -32656319 -24767142 Derived
Source
2022 2022-01-01 – 2022-12-310 57601000 Derived -57601000 -3376000 Derived -54225000 -21455000 Derived
Source
2023 2023-01-01 – 2023-12-310 25708000 Derived -25708000 -4868000 Derived -20840000 -20032000 Derived
Source
2024 2024-01-01 – 2024-12-311000000 23409000 Derived -22409000 -2424000 Derived -19985000 -19356000 Derived
Source
2025 2025-01-01 – 2025-12-31200000 18409000 Derived -18209000 -1623000 Derived -16586000 -15977000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 200K 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.38.1M28.6M19.1M9.5M0.0201520232025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2015Revenue22487566
2016Revenue35283868
2022Revenue0
2023Revenue0
2024Revenue1000000
2025Revenue200000

Revenue growth

Change in revenue from the same financial period one year earlier.

-80% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.68%28%-12%-51%-91%201520232025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2015Year over yearNo prior comparable period
2016Year over year56.9%
2022Year over yearNo prior comparable period
2023Year over yearNo prior comparable period
2024Year over yearNo prior comparable period
2025Year over year-80%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -9,104.5% 2025
Net margin -8,293% 2025
Free cash flow margin -7,988.5% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.728%-1,912%-4,552%-7,193%-9,833%201520232025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2015Operating margin-506.3%
2016Operating margin-83.6%
2022Operating marginNot reported
2023Operating marginNot reported
2024Operating margin-2,240.9%
2025Operating margin-9,104.5%
2015-12-31Net marginNot reported
2016Net margin-92.6%
2022Net marginNot reported
2023Net marginNot reported
2024Net margin-1,998.5%
2025Net margin-8,293%
2015Free cash flow marginNot reported
2016Free cash flow margin-70.2%
2022Free cash flow marginNot reported
2023Free cash flow marginNot reported
2024Free cash flow margin-1,935.6%
2025Free cash flow margin-7,988.5%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -15.9M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.9M-5.0M-11.8M-18.7M-25.6M201520232025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2015Operating cash flowNot reportedNo source recorded
2016Operating cash flow-23667682
2022Operating cash flow-21170000
2023Operating cash flow-20032000
2024Operating cash flow-19356000
2025Operating cash flow-15949000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -16M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.0M-5.2M-12.4M-19.6M-26.7M201520232025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2015Free cash flowUnavailableNo source recorded
2016Free cash flow-24767142
2022Free cash flow-21455000
2023Free cash flow-20032000
2024Free cash flow-19356000
2025Free cash flow-15977000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

17.7% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.64%48%32%16%0%201520232025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2015Liabilities / assets59.3%
2016Liabilities / assets56.1%
2022Liabilities / assets9.2%
2023Liabilities / assets12.4%
2024Liabilities / assets16.2%
2025Liabilities / assets17.7%

Current assets to current liabilities

Current assets divided by current liabilities.

5.76× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.12.16×9.12×6.08×3.04×0.00×201520232025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2015Current assets / current liabilities1.39×
2016Current assets / current liabilities1.16×
2022Current assets / current liabilities11.26×
2023Current assets / current liabilities8.18×
2024Current assets / current liabilities6.16×
2025Current assets / current liabilities5.76×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2016 2016-01-01 – 2016-12-31
−USD 32.66 million
Exact value

Exact value: -32656319 USD

2016-01-01 – 2016-12-31: -32656319 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 23.67 million
Exact value

Exact value: -23667682 USD

2016-01-01 – 2016-12-31: -23667682 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.1 million
Exact value

Exact value: 1099460 USD

2016-01-01 – 2016-12-31: 1099460 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 24.77 million
Calculation and evidence

-23667682 − 1099460 USD

Exact free cash flow: -24767142 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2017 2017-01-01 – 2017-12-31
USD 22.98 million
Exact value

Exact value: 22979000 USD

2017-01-01 – 2017-12-31: 22979000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 20.88 million
Exact value

Exact value: -20876000 USD

2017-01-01 – 2017-12-31: -20876000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 135,000
Exact value

Exact value: 135000 USD

2017-01-01 – 2017-12-31: 135000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 21.01 million
Calculation and evidence

-20876000 − 135000 USD

Exact free cash flow: -21011000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2018 2018-01-01 – 2018-12-31
−USD 16.17 million
Exact value

Exact value: -16167000 USD

2018-01-01 – 2018-12-31: -16167000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 19.99 million
Exact value

Exact value: -19986000 USD

2018-01-01 – 2018-12-31: -19986000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 134,000
Exact value

Exact value: 134000 USD

2018-01-01 – 2018-12-31: 134000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 20.12 million
Calculation and evidence

-19986000 − 134000 USD

Exact free cash flow: -20120000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 19.36 million
Exact value

Exact value: -19361000 USD

2019-01-01 – 2019-12-31: -19361000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 18.88 million
Exact value

Exact value: -18882000 USD

2019-01-01 – 2019-12-31: -18882000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 0
Exact value

Exact value: 0 USD

2019-01-01 – 2019-12-31: 0 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 18.88 million
Calculation and evidence

-18882000 − 0 USD

Exact free cash flow: -18882000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 8.15 million
Exact value

Exact value: -8150000 USD

2020-01-01 – 2020-12-31: -8150000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 8.82 million
Exact value

Exact value: -8823000 USD

2020-01-01 – 2020-12-31: -8823000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 20,000
Exact value

Exact value: 20000 USD

2020-01-01 – 2020-12-31: 20000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 8.84 million
Calculation and evidence

-8823000 − 20000 USD

Exact free cash flow: -8843000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 27.47 million
Exact value

Exact value: -27466000 USD

2021-01-01 – 2021-12-31: -27466000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 22.25 million
Exact value

Exact value: -22245000 USD

2021-01-01 – 2021-12-31: -22245000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 60,000
Exact value

Exact value: 60000 USD

2021-01-01 – 2021-12-31: 60000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 22.31 million
Calculation and evidence

-22245000 − 60000 USD

Exact free cash flow: -22305000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 54.23 million
Exact value

Exact value: -54225000 USD

2022-01-01 – 2022-12-31: -54225000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 21.17 million
Exact value

Exact value: -21170000 USD

2022-01-01 – 2022-12-31: -21170000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 285,000
Exact value

Exact value: 285000 USD

2022-01-01 – 2022-12-31: 285000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 21.46 million
Calculation and evidence

-21170000 − 285000 USD

Exact free cash flow: -21455000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 20.84 million
Exact value

Exact value: -20840000 USD

2023-01-01 – 2023-12-31: -20840000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 20.03 million
Exact value

Exact value: -20032000 USD

2023-01-01 – 2023-12-31: -20032000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 0
Exact value

Exact value: 0 USD

2023-01-01 – 2023-12-31: 0 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 20.03 million
Calculation and evidence

-20032000 − 0 USD

Exact free cash flow: -20032000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 19.99 million
Exact value

Exact value: -19985000 USD

2024-01-01 – 2024-12-31: -19985000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 19.36 million
Exact value

Exact value: -19356000 USD

2024-01-01 – 2024-12-31: -19356000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 0
Exact value

Exact value: 0 USD

2024-01-01 – 2024-12-31: 0 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 19.36 million
Calculation and evidence

-19356000 − 0 USD

Exact free cash flow: -19356000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−USD 16.59 million
Exact value

Exact value: -16586000 USD

2025-01-01 – 2025-12-31: -16586000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 15.95 million
Exact value

Exact value: -15949000 USD

2025-01-01 – 2025-12-31: -15949000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 28,000
Exact value

Exact value: 28000 USD

2025-01-01 – 2025-12-31: 28000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 15.98 million
Calculation and evidence

-15949000 − 28000 USD

Exact free cash flow: -15977000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

176 filings · 5,048 latest values · 5,048 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0000320017, 320017, CLBS, LSTA, NBS, edgar:320017

Also known as CALADRIUS BIOSCIENCES, INC., CORNICHE GROUP INC /DE, Caladrius Biosciences, Inc., LISATA THERAPEUTICS, INC., Lisata Therapeutics, Inc., NEOSTEM, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE